ClinicalTrials.govpublic full text
Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
locally advanced unresectable esophageal squamous cell carcinoma, esophageal carcinoma, definitive chemoradiotherapy, immunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 853036
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.